Tag: precision immunotherapy
CAR T cell therapy targets mutant calreticulin in myelofibrosis: new hope for precision cancer immunotherapy
A new CAR T cell therapy engineered to target mutant calreticulin successfully depleted disease-driving cells in myelofibrosis xenografts and human…
Submit Your Paper to GMJ
No APC until January 2027.